Professor Steven Chadban

Clinical Professor
Medicine, Central Clinical School
Bosch Institute

Telephone +61 2 9515 6600
Fax +61 2 9515 6329

Map

Research interests

Chronic kidney disease, macrophages, transplantation

Selected grants

2014

  • Discovering novel diagnostic and prognostic markers in solid organ transplantation allograft rejection; Chadban S, Shackel N; RPA Transplant Institute/Research Support.
  • Targeting Innate Immunity Through Hmgb1 To Prevent Diabetic Nephropathy; Chadban S, Wu H; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • QX100 Droplet Digital PCR system for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Richardson D, Kril J, Murphy C, Vandenberg R, Rendina L, Dos Remedios C, Ju Y, Kovacevic Z, Lyons G, Sutherland G, Lay P, Ammit A, Lai D, Morris B, Day M, Dong Q, Bao B, Huang M, Camp A, Boyer M, Whittington R, Byrne M, Hanrahan J, Fu D, Jansson P, Lane D, Bagley E, Hibbs D, Zhang D, Fraser S, Scolyer R, Black J, Halliday G, Christie M, Zreiqat H, Murray M, Slobedman B, Naylor M, Burgess J, Triccas J, Mason R, Chadban S, Combes V, Lovicu F, McLennan S, Kalinowski D, Sharland A, Johnstone D, Groundwater P, Dixon K, Zhou F, Lovejoy D, Lu Z, Zhu L, Goldsbury C, Witting P, Buckland M, Assinder S, Purdie (Williams) A, Codd R, Owens T, Hambly B; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2012

  • TOLERANCE OR REJECTION - THE ROLE OF INNATE IMMUNITY IN DETERMINING THE FATE OF A KIDNEY ALLOGRAFT; Chadban S, Wu H, Alexander S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • GeneAtlas Personal Microarray System; Richardson D, Scolyer R, Stocker R, Weninger W, Black J, Allen D, Murray M, Mason R, Twigg S, King N, Horvath L, Lovicu F, Lee C, Halliday G, Lovejoy D, Joshua D, Sharland A, Roufogalis B, Hambly B, Morris B, Bao B, Bishop A, Hibbs D, Lane D, Zhou F, Hanrahan J, Dixon K, Rendina L, Byrne M, Naylor M, Cole N, Jansson P, Dong Q, Codd R, Payne R, Assinder S, Chadban S, Fraser S, McLennan S, Suryo Rahmanto A, Lai D, Yu Y, Ju Y, Buckland M, Kovacevic Z, Saletta F, Zreiqat H, Kalinowski D, Groundwater P, Simes R, Zhang D, Boyer M, Murphy C; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Bruker Daltonics autoflex speed MALDI-TOF/TOF mass spectrometer; Baxter R, Halliday G, Marsh D, Gill A, Clarke S, Smith R, Little C, Jackson C, O'Neill C, Murphy C, Sharland A, Chadban S, Mason R, Assinder S, Verdurand M, Richardson D, Machaalani R, Hambly B, Chan-Ling T, Dos Remedios C, Holsinger D, Lay P; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Strategies to achieve kidney transplant tolerance in a clinically-relevant model; Sharland A, Chadban S, Bishop A, Wu H; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Breaking down the barriers to transplantation tolerance; Sharland A, Chadban S, Bishop A, Wu H; Heart Foundation of Australia/Grants-in-Aid.
  • PyroMark Q96 ID system; Richardson D, Stone J, Black J, King N, Mason R, Hunt N, Kril J, Murray M, Scolyer R, Halliday G, Vandenberg R, McMinn P, Chadban S, Byrne M, Ryan R, Dong Q, Lee C, Bishop A, Haass N, Fraser S, Hambly B, Sharland A, Kalinowski D, Assinder S, Yu Y, Bao B, Ju Y, Lovejoy D, Buckland M, Lane D, Dos Remedios C, Kovacevic Z, Sutherland G, Zhang D, Morris B, Suryo Rahmanto A, Murphy C; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2010

  • The Role of Toll-like Receptors in Diabetic Nephropathy; Chadban S, Pollock C, Wu H, Panchapakesan U; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Community preferences for organ donation and allocation in Australia; Howard K, Jan S, Cass A, Rose J, Chadban S, Allen R; Australian Research Council (ARC)/Discovery Projects (DP).

2008

  • Targeting innate immune receptors to prevent chronic dysfunction of the transplanted kidney; Chadban S, Wu H; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Liquid and chemical handling equipment; Bishop A, Chadban S, Sharland A, Allen R; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Improving population health by a multidisciplinary, multi-method focus kidney disease of the young, the old, and of Indigenous Australians; Craig J, Cass A, Irwig L, Chadban S, McDonald S, Devitt J, Macaskill P, Jones M, Howard K, Salkeld G; National Health and Medical Research Council (NHMRC)/Capacity Building Grant.
  • The role of toll like receptors in chronic allograft nephropathy; Wu H, Chen G, Chadban S; Kidney Health Australia/Research Grants.

2006

  • Interplay between innate and adaptive immunity in kidney allograft rejection; Chadban S, Wu H, Sharland A; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • Collaborative facility for gene measurement and expression; Bishop A, Sharland A, Chadban S, Allen R; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Cooled gradient palm cycler and rotor-shake genie; Bishop A, Sharland A, Allen R, Gorrell M, Chadban S; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • A study of the economic impact of the burden of kidney and urinary tract disease in Australia; Cass A, Howard K, Salkeld G, Craig J, Chadban S, McDonald S; Kidney Health Australia/Research Grants.

2004

  • An integrated approach to application of novel developments in basic transplantation research to cli; Chadban S, Hennessy A, Allen R, McCaughan G, Bishop A, Sharland A, Eris J; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Centre of clinical research excellence in renal medicine; Walker R, Atkins R, Craig J, Chadban S, Irwig L, Harris D, O'Connell P, Walker R, Chadban S, Atkins R, Irwig L; National Health and Medical Research Council (NHMRC)/Centre of Clinical Research Excellence.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Chan, M., Chadban, S. (2013). Nutritional Management of Kidney Transplant Recipients. In Joel D. Kopple, Shaul G Massry, Kamyar Kalantar-Zadeh (Eds.), Nutritional Management of Renal Disease, (pp. 563-580). London, UK: Elsevier.
  • Chadban, S., Clayton, P., Excell, L., Campbell, S., McDonald, S. (2010). Transplantation. In S. McDonald, L. Excell, B. Livingstone (Eds.), ANZDATA Registry Report 2010, (pp. 1-31). Australia: ANZDATA Registry Australia.
  • Chadban, S. (2007). Chronic Allograft Dysfunction. In David Harris (Eds.), Clinical Cases in Kidney Disease. Australia: McGraw Hill.

Journals

  • Wu, H., Steenstra, R., de Boer, E., Zhao, C., Ma, J., van der Stelt, J., Chadban, S. (2014). Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney International, 85(4), 824-832. [More Information]
  • Ma, J., Wu, H., Zhao, C., Panchapakesan, U., Pollock, C., Chadban, S. (2014). Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. International Journal of Clinical and Experimental Pathology, 7(2), 481-495.
  • Wu, H., Chadban, S. (2014). Roles of Toll-like receptors in transplantation. Current opinion in organ transplantation, 19(1), 1-7. [More Information]
  • Getts, D., Terry, R., Getts, M., Deffrasnes, C., Müller, M., Van Vreden, C., Ashhurst, T., Chami, B., McCarthy, D., Wu, H., Ma, J., Witting, P., Campbell, I., Reilly, D., White, M., Cordwell, S., Chadban, S., Bao, B., King, N., et al (2014). Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine, 6(219), Article number 219ra7. [More Information]
  • Kwan, T., Chadban, S., McKenzie, P., Saunders, J. (2013). Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria. Nephrology, 18(3), 241-242. [More Information]
  • Wyld, M., Clayton, P., Morton, R., Chadban, S. (2013). Anti-Coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology, 18(12), 783-789. [More Information]
  • Irving, M., Tong, A., Jan, S., Wong, G., Cass, A., Allen, R., Craig, J., Chadban, S., Rose, J., Howard, K. (2013). Community preferences for the allocation of organs for transplantation: a focus group study. Nephrology, Dialysis, Transplantation, 28(8), 2187-2193. [More Information]
  • Naresh, C., Hayen, A., Weening, A., Craig, J., Chadban, S. (2013). Day-to-Day Variability in Spot Urine Albumin-Creatinine Ratio. American Journal of Kidney Diseases, 62(6), 1095-1101. [More Information]
  • Chadban, S., Eris, J., Russ, G., Campbell, S., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thomson, N., Hutchison, B., et al (2013). Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients. Nephrology, 18(1), 63-70. [More Information]
  • Sparke, C., Moon, L., Green, F., Mathew, T., Cass, A., Chadban, S., Chapman, J., Hoy, W., McDonald, S. (2013). Estimating the Total Incidence of Kidney Failure in Australia Including Individuals Who Are Not Treated by Dialysis or Transplantation. American Journal of Kidney Diseases, 61(3), 413-419. [More Information]
  • Didsbury, M., McGee, R., Tong, A., Craig, J., Chapman, J., Chadban, S., Wong, G. (2013). Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Transplantation, 95(5), 679-687. [More Information]
  • Vacher-Coponat, H., McDonald, S., Clayton, P., Loundou, A., Allen, R., Chadban, S. (2013). Inferior early posttransplant outcomes for recipients of right versus left deceased donor kidneys: an ANZDATA registry analysis. American Journal of Transplantation, 13(2), 399-405. [More Information]
  • Wyburn, K., Chadban, S., Kwan, T., Alexander, S., Wu, H. (2013). Interleukin-18 binding protein therapy is protective in adriamycin nephropathy. AJP: Renal Physiology (Online), 304(1), F68-F76. [More Information]
  • Lim, W., Clayton, P., Wong, G., Campbell, S., Cohney, S., Russ, G., Chadban, S., McDonald, S. (2013). Outcomes of Kidney Transplantation From Older Living Donors. Transplantation, 95(1), 106-113. [More Information]
  • Wyld, M., Clayton, P., Jesudason, S., Chadban, S., Alexander, S. (2013). Pregnancy Outcomes for Kidney Transplant Recipients. American Journal of Transplantation, 13(12), 3173-3182. [More Information]
  • Gill, J., Schaeffner, E., Chadban, S., Dong, J., Rose, C., Johnston, O., Gill, J. (2013). Quantification of the early risk of death in elderly kidney transplant recipients. American Journal of Transplantation, 13(2), 427-432. [More Information]
  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Howard, K. (2013). Rationing scarce organs for transplantation: Healthcare provider perspectives on wait-listing and organ allocation. Clinical Transplantation, 27(1), 60-71. [More Information]
  • Damasiewicz, M., Magliano, D., Daly, R., Gagnon, C., Lu, Z., Sikaris, K., Ebeling, P., Chadban, S., Atkins, R., Kerr, P., et al (2013). Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. American Journal of Kidney Diseases, 62(1), 58-66. [More Information]
  • Ko, H., Yin, J., Wyburn, K., Wu, H., Eris, J., Hambly, B., Chadban, S. (2013). Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction. Nephrology, Dialysis, Transplantation, 28(2), 327-336. [More Information]
  • Mudaliar, H., Pollock, C., Gangadharan Komala, M., Chadban, S., Wu, H., Panchapakesan, U. (2013). The role of toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. AJP: Renal Physiology (Online), 305(2), F143-F154. [More Information]
  • Storhaug, H., Norvik, J., Toft, I., Eriksen, B., Lochen, M., Zykova, S., Solbu, M., White, S., Chadban, S., Jenssen, T. (2013). Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: A gender specific analysis from The Tromso Study. BMC Cardiovascular Disorders, 13(11), 1-10. [More Information]
  • Damasiewicz, M., Magliano, D., Daly, R., Gagnon, C., Lu, Z., Ebeling, P., Chadban, S., Atkins, R., Kerr, P., Shaw, J., et al (2012). 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrology, 13(1), 1-8. [More Information]
  • Polkinghorne, K., Chadban, S. (2012). A decade after the KDOQI CKD guidelines: a perspective from Australia. American Journal of Kidney Diseases, 60(5), 725-726. [More Information]
  • Wu, H., Noordmans, G., O'Brien, M., Ma, J., Zhao, C., Zhang, G., Kwan, T., Alexander, S., Chadban, S. (2012). Absence of MyD88 Signaling Induces Donor-Specific Kidney Allograft Tolerance. Journal of the American Society of Nephrology, 23(10), 1701-1716. [More Information]
  • Lim, W., Clayton, P., Wong, G., Dogra, G., Budgeon, C., Murray, K., Campbell, S., Cohney, S., Russ, G., Polkinghorne, K., Chadban, S., et al (2012). Association between initial and pretransplant dialysis modality and graft and patient outcomes in live- and deceased-donor renal transplant recipients. Transplant International, 25(10), 1032-1040. [More Information]
  • Johnson, D., Jones, G., Mathew, T., Ludlow, M., Chadban, S., Usherwood, T., Polkinghorne, K., Colagiuri, S., Jerums, G., Macisaac, R., et al (2012). Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Medical Journal of Australia, 197(4), 1-6. [More Information]
  • Irving, M., Tong, A., Jan, S., Cass, A., Chadban, S., Allen, R., Craig, J., Wong, G., Howard, K. (2012). Community attitudes to deceased organ donation: a focus group study. Transplantation, 93(10), 1064-1069. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Naresh, C., Hayen, A., Craig, J., Chadban, S. (2012). Day-to-Day Variability in Spot Urine Protein-Creatinine Ratio Measurements. American Journal of Kidney Diseases, 60(4), 561-566. [More Information]
  • Irving, M., Tong, A., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J., Wong, G., Howard, K. (2012). Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. Nephrology, Dialysis, Transplantation, 27(6), 2526-2533. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Lim, W., Chadban, S., Clayton, P., Budgeon, C., Murray, K., Campbell, S., Cohney, S., Russ, G., McDonald, S. (2012). Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clinical Transplantation, 26(4), E428-E437. [More Information]
  • Chadban, S., Barraclough, K., Campbell, S., Clark, C., Coates, P., Cohney, S., Cross, N., Eris, J., Henderson, L., Howell, M., O'Connell, P., Webster, A., Wong, G., et al (2012). KHA-CARI guideline: KHA-CARI Adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology, 17(3), 204-214. [More Information]
  • Lim, W., Dogra, G., Chadban, S., Campbell, S., Clayton, P., Cohney, S., Russ, G., McDonald, S. (2012). Lack of impact of donor age on patient survival for renal transplant recipients (greater than or equal to) 60 years. Transplant International, 25(4), 401-408. [More Information]
  • Clayton, P., McDonald, S., Chapman, J., Chadban, S. (2012). Mycophenolate Versus Azathioprine for Kidney Transplantation: A 15-Year Follow-Up of a Randomized Trial. Transplantation, 94(2), 152-158. [More Information]
  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Marren, N., Howard, K. (2012). Patient preferences for the allocation of deceased donor kidneys for transplantation: a mixed methods study. BMC Nephrology, 13(1), 1-9. [More Information]
  • Roberts, D., Jiang, S., Chadban, S. (2012). The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients-A Systematic Review. Transplantation, 94(8), 775-783. [More Information]
  • Lim, W., Chadban, S., Campbell, S., Cohney, S., Russ, G., McDonald, S. (2011). A review of utility-based allocation strategies to maximize graft years of deceased donor kidneys. Nephrology, 16(4), 368-376. [More Information]
  • Howard, K., Jan, S., Rose, J., Chadban, S., Allen, R., Irving, M., Tong, A., Wong, G., Craig, J., Cass, A. (2011). Community Preferences for the Allocation & Donation of Organs - The PAraDOx Study. BMC Public Health, 11(386), 386-1-386-7. [More Information]
  • White, S., Yu, R., Craig, J., Polkinghorne, K., Atkins, R., Chadban, S. (2011). Diagnostic Accuracy of Urine Dipsticks for Detection of Albuminuria in the General Community. American Journal of Kidney Diseases, 58(1), 19-28. [More Information]
  • Chan, M., Patwardhan, A., Ryan, C., Trevillian, P., Chadban, S., Westgarth, F., Fry, K. (2011). Evidence-based guidelines for the nutritional management of adult kidney transplant recipients. Journal of Renal Nutrition, 21(1), 47-51. [More Information]
  • Maple-Brown, L., Cunningham, J., Hodge, A., Weeramanthri, T., Dunbar, T., Lawton, P., Zimmet, P., Chadban, S., Polkinghorne, K., Shaw, J., et al (2011). High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study. BMC Public Health, 11, 346-1-346-8. [More Information]
  • White, S., Dunstan, D., Polkinghorne, K., Atkins, R., Cass, A., Chadban, S. (2011). Physical inactivity and chronic kidney disease in Australian adults: The AusDiab study. Nutrition, Metabolism and Cardiovascular Diseases, 21(2), 104-112. [More Information]
  • White, S., Polkinghorne, K., Chadban, S. (2011). Population prevalance of proteinuria and diagnostic accuracy of urine dipsticks. American Journal of Kidney Diseases, 58. [More Information]
  • Clayton, P., McDonald, S., Chadban, S. (2011). Steroids and Recurrent IgA Nephropathy After Kidney Transplantation. American Journal Of Transplantation, 11(8), 1645-1649. [More Information]
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Chen, G., Wu, H., Ma, J., Chadban, S., Sharland, A. (2011). Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 26(12), 3873-3881. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Cass, A., Campbell, D., Tong, A., Tong, A., Colagiuri, R., Colagiuri, S., Craig, J., et al (2010). Assessment of kidney function in type 2 diabetes. Nephrology, 15(S1), S146-S161. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Campbell, D., Thomas, M., Jerums, G., Nicholls, K., Cass, A., Tong, A., Mangos, G., et al (2010). Assessment of kidney function in type 2 diabetes. Nephrology, 15 Sup1, S146-161. [More Information]
  • Matsushita, K., van der Velde, M., Astor, B., Woodward, M., Levey, A., de Jong, P., Coresh, J., Gansevoort, R., Tonelli, M., Atkins, R., et al (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet, 375(9731), 2073-2081. [More Information]
  • Tong, A., Howard, K., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J. (2010). Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation, 89(7), 796-805. [More Information]
  • White, S., Polkinghorne, K., Atkins, R., Chadban, S. (2010). Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. American Journal of Kidney Diseases, 55(4), 660-670. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Cass, A., Campbell, D., Nicholls, K., Tong, A., Mangos, G., et al (2010). Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes. Nephrology, 15(Sup 1), S195-S203. [More Information]
  • Howard, K., White, S., Salkeld, G., McDonald, S., Craig, J., Chadban, S., Cass, A. (2010). Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis. Value in Health, 13(2), 196-208. [More Information]
  • Lim, W., Chang, S., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Donor-recipient age matching improves years of graft function in deceased-donor kidney transplantation. Nephrology, Dialysis, Transplantation, 25(9), 3082-3089. [More Information]
  • Lim, W., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transplant International, 23(12), 1207-1215. [More Information]
  • Wu, H., Ma, J., Wang, P., Corpuz, T., Panchapakesan, U., Wyburn, K., Chadban, S. (2010). HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. Journal of the American Society of Nephrology, 21(11), 1878-1890. [More Information]
  • Lim, W., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients. Nephrology, 15(3), 368-376. [More Information]
  • Tapp, R., O'Neil, A., Shaw, J., Zimmet, P., Oldenburg, B., Chadban, S., AusDiab Study, G. (2010). Is There a Link Between Components of Health-Related Functioning and Incident Impaired Glucose Metabolism and Type 2 Diabetes?: The Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care, 33(4), 757-762. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Chadban, S., Wu, H., Hughes, J. (2010). Macrophages and Kidney Transplantation. Seminars in Nephrology, 30(3), 278-289. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Cass, A., Campbell, D., Nicholls, K., Tong, A., Mangos, G., et al (2010). Prevention and management of chronic kidney disease in type 2 diabetes. Nephrology, 15(S1), S162-S194. [More Information]
  • Smith, G., Trauer, T., Kerr, P., Chadban, S. (2010). Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. American Journal of Kidney Diseases, 55(4), 698-707. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]
  • Pilmore, H., Dent, H., Chang, S., McDonald, S., Chadban, S. (2010). Reduction in Cardiovascular Death After Kidney Transplantation. Transplantation, 89(7), 851-857. [More Information]
  • Mathew, T., Corso, O., Ludlow, M., Boyle, A., Cass, A., Chadban, S., Joyner, B., Shephard, M., Usherwood, T. (2010). Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney International, 77(Supplement 116), S9-S16. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Lynch, B., White, S., Owen, N., Healy, G., Chadban, S., Atkins, R., Dunstan, D. (2010). Television Viewing Time and Risk of Chronic Kidney Disease in Adults: The AusDiab Study. Annals of Behavioral Medicine, 40(3), 265-274. [More Information]
  • White, S., Polkinghorne, K., Cass, A., Shaw, J., Atkins, R., Chadban, S. (2009). Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrology, Dialysis, Transplantation, 24(8), 2464-2472. [More Information]
  • Fry, K., Patwardhan, A., Ryan, C., Trevillian, P., Chadban, S., Westgarth, F., Chan, M. (2009). Development of evidence-based guidelines for the nutritional management of adult kidney transplant recipients. Journal of Renal Nutrition, 19(1), 101-104. [More Information]
  • Villar, E., Polkinghorne, K., Chang, S., Chadban, S., McDonald, S. (2009). Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease. Diabetologia: clinical and experimental diabetes and metabolism, 52(12), 2536-2541. [More Information]
  • Lim, W., Chang, S., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2009). Interleukin-2 Receptor Antibody Reduces Rejection Rates and Graft Loss in Live-Donor Kidney Transplant Recipients. Transplantation, 88(10), 1208-1213. [More Information]
  • White, S., Perkovic, V., Cass, A., Chang, C., Poulter, N., Spector, T., Haysom, L., Craig, J., Al Salmi, I., Chadban, S., Huxley, R. (2009). Is Low Birth Weight an Antecedent of CKD in Later Life? A Systematic Review of Observational Studies. American Journal of Kidney Diseases, 54(2), 248-261. [More Information]
  • Tong, A., Sainsbury, P., Chadban, S., Walker, R., Harris, D., Carter, S., Hall, B., Hawley, C., Craig, J. (2009). Patients' Experiences and Perspectives of Living With CKD. American Journal of Kidney Diseases, 53(4), 689-700. [More Information]
  • Howard, K., Salkeld, G., White, S., McDonald, S., Chadban, S., Craig, J., Cass, A. (2009). The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology, 14(1), 123-132. [More Information]
  • Kondalsamy-Chennakesavan, S., Hoy, W., Wang, Z., Briganti, E., Polkinghorne, K., Chadban, S., Shaw, J. (2008). Anthropometric measurements of Australian Aboriginal adults living in remote areas: Comparison with nationally representative findings. American Journal of Human Biology, 20, 317-324. [More Information]
  • Walker, R., Thomas, M., Goodman, D., Campbell, S., Chadban, S., AUS-13 Study, G. (2008). Combination therapy with tacrolimus and mycophenolate mofetil: effects of early and late minimization of mycophenolate mofetil after renal transplant. Clinical Transplantation, 22(5), 594-602. [More Information]
  • Ko, H., Hambly, B., Eris, J., Levidiotis, V., Wyburn, K., Wu, H., Chadban, S., Yin, J. (2008). Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A. Transplant Immunology, 20(1-2), 99-105. [More Information]
  • Perkovic, V., Cass, A., Patel, A., Suriyawongpaisal, P., Barzi, F., Chadban, S., MacMahon, S., Neal, B. (2008). High prevalence of chronic kidney disease in Thailand. Kidney International, 73(4), 473-479. [More Information]
  • White, S., Chadban, S., Jan, S., Chapman, J., Cass, A. (2008). How can we achieve global equity in provision of renal replacement therapy. Bulletin of the World Health Organization, 86(3), 229-237. [More Information]
  • Wu, H., Craft, M., Wang, P., Wyburn, K., Chen, G., Ma, J., Hambly, B., Chadban, S. (2008). IL-18 Contributes to Renal Damage after Ischemia-Reperfusion. Journal of the American Society of Nephrology, 19(12), 2331-2341. [More Information]
  • Chadban, S., Morris, R., Hirschc, H., Bunnapradist, S., Arns, W., Budde, K. (2008). Immunosuppression in renal transplantation: some aspects for the modern era. Transplantation Reviews, 22, 241-251. [More Information]
  • White, S., Polkinghorne, K., Cass, A., Shaw, J., Atkins, R., Chadban, S. (2008). Limited knowledge of kidney disease in a survey of AusDiab study participants. Medical Journal of Australia, 188(4), 204-208. [More Information]
  • Chadban, S. (2008). New-onset diabetes after transplantation - should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients? Nephrology, Dialysis, Transplantation, 23(6), 1816-1818. [More Information]
  • Garry, L., Mawson, J., George, C., Chadban, S., Allen, R., Eris, J., Verran, D. (2008). Outcomes of Patients Seeking Commercial Renal Allograft Transplantation Outside of Australia. Transplantation, 86(2S (supplement)), 266-266.
  • Tong, A., Sainsbury, P., Carter, S., Hall, B., Harris, D., Walker, R., Hawley, C., Chadban, S., Craig, J. (2008). Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(10), 3206-3214. [More Information]
  • White, S., McGeechan, K., Jones, M., Cass, A., Chadban, S., Polkinghorne, K., Perkovic, V., Roderick, P. (2008). Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand. American Journal of Public Health, 98(7), 1306-1313. [More Information]
  • Chang, S., Russ, G., Chadban, S., Campbell, S., McDonald, S. (2008). Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991–2005. Nephrology, 13(2), 171-176. [More Information]
  • Chadban, S., Baines, L., Polkinghorne, K., Jeffreys, A., Dogra, S., Kanganas, C., Irish, A., Eris, J., Walker, R. (2007). Anemia After Kidney Transplantation Is Not Completely Explained by Reduced Kidney Function. American Journal of Kidney Diseases, 49(2), 301-309. [More Information]
  • Killen, J., Chadban, S. (2007). Antithymocyte globulin versus basiliximab in renal transplantation. New England Journal of Medicine, 356(6), 634-635. [More Information]
  • McClintock, C., Cass, A., Chadban, S. (2007). How to treat: Chronic Kidney Disease. Australian Doctor, (February 2), 19-23.
  • Magliano, D., Polkinghorne, K., Barr, E., Su, Q., Chadban, S., Zimmet, P., Shaw, J., Atkins, R. (2007). HPLC-Detected Albuminuria Predicts Mortality. Journal of the American Society of Nephrology, 18(12), 3171-3176. [More Information]
  • McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney Transplant Rejection in Australia and New Zealand: Relationships between rejection and graft outcome. American Journal Of Transplantation, 7(5), 1201-1208. [More Information]
  • Hoy, W., Kondalsamy-Chennakesavan, S., Wang, Z., Briganti, E., Shaw, J., Polkinghorne, K., Chadban, S. (2007). Quantifying the excess risk for proteinuria, hypertension and diabetes in Australian Aborigines: comparison of profiles in three remote communities in the Northern Territory with those in the AusDiab study. Australian and New Zealand Journal of Public Health, 31(2), 177-183. [More Information]
  • Yi, S., Wang, Y., Chandra, A., O'Hara, J., Wu, J., Ouyang, L., Burgess, J., Hawthorne, W., Wu, H., Chadban, S., O'Connell, P. (2007). Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer. Transplantation, 83(5), 615-623. [More Information]
  • Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J., Uchida, K., Pescovitz, M., Marchetti, P., Tuncer, M., Chadban, S., et al (2007). Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus. American Journal Of Transplantation, 7(6), 1506-1514. [More Information]
  • Wu, H., Chen, G., Wyburn, K., Bertolino, P., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. Journal of Clinical Investigation, 117(10), 2847-2859. [More Information]
  • Chang, S., Russ, G., Chadban, S., Campbell, S., McDonald, S. (2007). Trends in Kidney Transplantation in Australia and New Zealand, 1993-2004. Transplantation, 84(5), 611-618. [More Information]
  • Chadban, S., Campbell, S., Russ, G., Walker, R., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thompson, N., Hutchison, B., et al (2006). A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. Immunology and Cell Biology, 84(3), A6-A6.
  • Buchler, M., Chadban, S., Cole, E., Midtvedt, K., Thervet, E., Prestele, H., Keown, P. (2006). Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Nephrology, Dialysis, Transplantation, 21(1), 197. [More Information]
  • Wyburn, K., Wu, H., Chen, G., Yin, J., Eris, J., Chadban, S. (2006). Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. American Journal Of Transplantation, 6(11), 2612-2621. [More Information]
  • Nguyen, D., Ping, F., Mu, W., Hill, P., Atkins, R., Chadban, S. (2006). Macrophage accumulation in human progressive diabetic nephropathy. Nephrology, 11(3), 226-231. [More Information]
  • Polkinghorne, K., Su, Q., Chadban, S., Shaw, J., Zimmet, P., Atkins, R. (2006). Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. American Journal of Kidney Diseases, 47(4), 604-613. [More Information]
  • Cass, A., Chadban, S., Atkins, R., White, S. (2005). Chronic kidney disease in the general population. Advances in Chronic Kidney Disease, 12(1), 5-13. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased Kidney Donor Suitability Guidelines. Nephrology, 10(Supplement 4), S116-S132. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased kidney donor suitability guidelines: Non-heart-beating donors. Nephrology, 10(S4), S116-S119. [More Information]
  • Benseler, V., Bishop, A., Chng, K., Watson, J., Wang, C., Dahlke, M., Koutalistras, N., Watts, A., Hawthorne, W., McKenzie, P., Hennessy, A., Pleass, H., Chadban, S., Schlitt, H., McCaughan, G., et al (2005). Development of a primate model to evaluate strategies to achieve long term renal allograft acceptance. Immunology and Cell Biology, 83(4 Suppl.), A26-A26.
  • Stefoni, S., Midtved, K., Cole, E., Thervet, E., Cockfield, S., Buchler, M., Toselli, L., Pallardo, L., Schena, F., Pilmore, H., Chadban, S., et al (2005). Efficacy and safety outcomes among de novo renal transplant recipients managed by C-2 monitoring of cyclosporine A microemulsion: Results of a 12-month, randomized, multicenter study. Transplantation, 79(5), 577-583. [More Information]
  • Chadban, S., Atkins, R. (2005). Glomerulonephritis. The Lancet, 365(9473), 1797-1806. [More Information]
  • Kusyk, T., Verran, D., Stewart, G., Ryan, B., Fisher, J., Tsacalos, K., Chadban, S., Eris, J. (2005). Increased risk of hemorrhagic complications in renal allograft recipients receiving systemic heparin early posttransplantation. Transplantation Proceedings, 37(2), 1026-1028. [More Information]
  • Blazik, M., Hutchinson, P., Jose, M., Polkinghorne, K., Holdsworth, S., Atkins, R., Chadban, S. (2005). Leukocyte phenotype and function predicts infection risk in renal transplant recipients. Nephrology, Dialysis, Transplantation, 20(10), 2226-2230. [More Information]
  • Wyburn, K., Wu, H., Yin, J., Jose, M., Eris, J., Chadban, S. (2005). Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrology, Dialysis, Transplantation, 20(4), 699-706. [More Information]
  • Wyburn, K., Jose, M., Wu, H., Atkins, R., Chadban, S. (2005). The Role of Macrophages in Allograft Rejection. Transplantation, 80(12), 1641-1647. [More Information]
  • Yu, R., Chadban, S., Svara, F., Sen, S., Eris, J. (2005). Two cases of delayed cyclosporin absorption leading to CsA exposure higher than that predicted by C2 monitoring alone. Nephrology, Dialysis, Transplantation, 20(8), 1745-1747. [More Information]
  • Chadban, S., Ierino, F. (2005). Welcome to the era of CKD and the eGFR: Estimating glomerular filtration rate using a simplified formula will lead to a vast increase in detection of chronic kidney disease in Australia [Editorial]. Medical Journal of Australia, 183(3), 117-118. [More Information]
  • Atkins, R., Polkinghorne, K., Briganti, E., Shaw, J., Zimmet, P., Chadban, S. (2004). Prevalence of albuminuria in Australia: The AusDiab Kidney Study. Kidney International, 66(Supplement 92), S22-S24.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment For Lupus Nephritis. Cochrane Database of Systematic Reviews, 1(CD002922), 1-79.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment Of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis Of Randomized Controlled Trials. American Journal of Kidney Diseases, 43(2), 197-208.
  • Atkins, R., Briganti, E., Zimmet, P., Chadban, S. (2003). Association between albuminuria and proteinuria in the general population: the AusDiab study. Nephrology, Dialysis, Transplantation, 18(10), 2170-2174.
  • Jose, M., Le Meur, Y., Atkins, R., Chadban, S. (2003). Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. American Journal Of Transplantation, 3(3), 294-300.
  • Thervet, E., Pfeffer, P., Scolari, M., Toselli, L., Pallardo, L., Chadban, S., Pilmore, H., Connolly, J., Buchler, M., Schena, F., et al (2003). Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation, 76(6), 903-908.
  • Jose, M., Ikezumi, Y., Van Rooijen, N., Atkins, R., Chadban, S. (2003). Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation, 76(7), 1015-1022.
  • Chadban, S., Briganti, E., Kerr, P., Dunstan, D., Welborn, T., Zimmet, P., Atkins, R. (2003). Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. Journal of the American Society of Nephrology, 14, S131-S138.
  • Smith, G., Trauer, T., Kerr, P., Chadban, S. (2003). Prospective psychosocial monitoring of living kiney donors using the SF-36 health survey. Transplantation, 76(5), 807-809.
  • Briganti, E., Shaw, J., Chadban, S., Zimmet, P., Welbron, T., McNeil, J., Atkins, R. (2003). Untreated hypertension among Australian adults: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Medical Journal of Australia, 179(3), 135-139.

Conferences

  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Marren, N., Howard, K. (2012). Patient Preferences For The Allocation Of Deceased Donor Kidneys For Transplantation: A Mixed Methods Study. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Howard, K., Irving, M., Cass, A., Rose, J., Chadban, S., Allen, R., Tong, A., Wong, G., Craig, J., Jan, S. (2011). Community preferences for the allocation and donation of organs - The PArADOx Study: Preferences for organ donation. 11th Congress of the International Society for Organ Donation and Procurement, Amsterdam, Netherlands: Elsevier.
  • Tong, A., Howard, K., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J. (2011). Systematic review and synthesis of quantitative and qualitative research: a worked example to assess community preferences. 19th Cochrane Colloquium, Hoboken, New Jersey: John Wiley & Sons.
  • Craig, J., Perkovic, V., Chadban, S., Cass, A., McDonald, S., Salkeld, G., Howard, K., White, S. (2008). Cost effectiveness of screening for the early diagnosis and treatment of risk factors for chronic kidney disease: a Markov Monte Carlo microsimulation using marck-E (model for the assessment of risk factors for chronic kidney disease - economics). 42nd Australia and New Zealand Society of Nephrology Annual Scientific Conference (2006), United States of America: Wiley-Blackwell Publishing.
  • Salkeld, G., Howard, K., McDonald, S., Cass, A., Chadban, S., White, S., Craig, J. (2006). Cost effectiveness of renal replacement therapy for patients with end stage kidney disease: a Markov microsimulation model. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., Cass, A., McDonald, S., Perkovic, V. (2006). Cost effectiveness of screening for the early diagnosis and treatment of risk factors for chronic kidney disease: A Markov Monte Carlo microsimulation using Marck-E. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Yu, R., Craig, J., Polkinghorne, K., Shaw, J., Atkins, R., Chadban, S. (2006). Dipstick urinalysis for the detection of proteinuria in the general community. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • McDonald, S., Howard, K., White, S., Craig, J., Chadban, S., Salkeld, G., Cass, A. (2006). Predicting future requirements for renal replacement therapy (RRT) in Australia. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Ko, H., Yin, J., Hambly, B., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2006). Rapamycin and Sanglifehrin A can inhibit interleukin-18 production from dendritic cells in vitro and in vivo. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Eykman, L., Mawson, J., Robertson, P., Chadban, S., Allen, R. (2006). The monetary cost of living kidney donation. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Yin, J., Ko, H., Wyburn, K., Wu, H., Hambly, B., Chadban, S., Eris, J. (2006). The role of IL-12 family cytokines in chronic allograft nephropathy. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Wu, H., Chen, G., Wyburn, K., Afifi, M., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2006). TLR4 activation mediates kidney ischemia reperfusion injury. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Ko, H., Yin, J., Hambly, B., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2005). Immunosuppressants rapamycin and sanglifehrin A inhibit bioactive IL-18 production by dendritic. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Wyburn, K., Wu, H., Yin, J., Jose, M., Eris, J., Chadban, S. (2005). Interleukin-18 is elevated in experimental renal allograft rejection. 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Buchler, M., Chadban, S., Cole, E., Midtvedt, K., Thervet, E., Prestele, H., Keown, O. (2005). Pharmacokinetics of cyclosporine-microemulsion after renal transplantation: How long does C2-monitoring add value? 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Yin, J., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2005). The role of IL-18 and IL-12 family in chronic allograft nephropathy. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Wu, H., Wyburn, K., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2005). Upregulation of NKG2D and it''s ligand RAE-1 in renal allografts may provide a link between innate and adaptive immunity in acute rejection. 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Wu, H., Wyburn, K., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2005). Upregulation of NKG2D and its ligand RAE-1 in renal allografts may provide a link between innate and adaptive immunity in acute rejection. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.

Patents

  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Nicholls, K., Mangos, G., Tong, A., Stack, A., McIsaac, R., Girgis, S., Colagiuri, S., Colagiuri, R., Craig, J. (2009).

Report

  • Cass, A., Chadban, S., Gallagher, M., Howard, K., Kneipp, E., McDonald, S., Snelling, P. (2007). Queensland Statewide Renal Health Services Plan 2007-2017 - Part Two: Current Service Analysis and Future Demand Predictions.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., McDonald, S., Perkovic, V., Cass, A. (2006). The cost-effectiveness of early detection and intervention to prevent the progression of Chronic Kidney Disease in Australia.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., McDonald, S., Perkovic, V., Cass, A. (2006). The Cost-Effectiveness of Early Detection and Intervention to Prevent the Progression of Chronic Kidney Disease in Australia.
  • Cass, A., Chadban, S., Craig, J., Howard, K., McDonald, S., Salkeld, G., White, S. (2006). The economic impact of end-stage kidney disease in Australia.
  • Cass, A., Chadban, S., Craig, J., Howard, H., McDonald, S., Salkeld, G., White, S. (2006). The Economic Impact of End-Stage Kidney Disease in Australia.

2014

  • Wu, H., Steenstra, R., de Boer, E., Zhao, C., Ma, J., van der Stelt, J., Chadban, S. (2014). Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney International, 85(4), 824-832. [More Information]
  • Ma, J., Wu, H., Zhao, C., Panchapakesan, U., Pollock, C., Chadban, S. (2014). Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. International Journal of Clinical and Experimental Pathology, 7(2), 481-495.
  • Wu, H., Chadban, S. (2014). Roles of Toll-like receptors in transplantation. Current opinion in organ transplantation, 19(1), 1-7. [More Information]
  • Getts, D., Terry, R., Getts, M., Deffrasnes, C., Müller, M., Van Vreden, C., Ashhurst, T., Chami, B., McCarthy, D., Wu, H., Ma, J., Witting, P., Campbell, I., Reilly, D., White, M., Cordwell, S., Chadban, S., Bao, B., King, N., et al (2014). Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine, 6(219), Article number 219ra7. [More Information]

2013

  • Kwan, T., Chadban, S., McKenzie, P., Saunders, J. (2013). Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria. Nephrology, 18(3), 241-242. [More Information]
  • Wyld, M., Clayton, P., Morton, R., Chadban, S. (2013). Anti-Coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology, 18(12), 783-789. [More Information]
  • Irving, M., Tong, A., Jan, S., Wong, G., Cass, A., Allen, R., Craig, J., Chadban, S., Rose, J., Howard, K. (2013). Community preferences for the allocation of organs for transplantation: a focus group study. Nephrology, Dialysis, Transplantation, 28(8), 2187-2193. [More Information]
  • Naresh, C., Hayen, A., Weening, A., Craig, J., Chadban, S. (2013). Day-to-Day Variability in Spot Urine Albumin-Creatinine Ratio. American Journal of Kidney Diseases, 62(6), 1095-1101. [More Information]
  • Chadban, S., Eris, J., Russ, G., Campbell, S., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thomson, N., Hutchison, B., et al (2013). Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients. Nephrology, 18(1), 63-70. [More Information]
  • Sparke, C., Moon, L., Green, F., Mathew, T., Cass, A., Chadban, S., Chapman, J., Hoy, W., McDonald, S. (2013). Estimating the Total Incidence of Kidney Failure in Australia Including Individuals Who Are Not Treated by Dialysis or Transplantation. American Journal of Kidney Diseases, 61(3), 413-419. [More Information]
  • Didsbury, M., McGee, R., Tong, A., Craig, J., Chapman, J., Chadban, S., Wong, G. (2013). Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. Transplantation, 95(5), 679-687. [More Information]
  • Vacher-Coponat, H., McDonald, S., Clayton, P., Loundou, A., Allen, R., Chadban, S. (2013). Inferior early posttransplant outcomes for recipients of right versus left deceased donor kidneys: an ANZDATA registry analysis. American Journal of Transplantation, 13(2), 399-405. [More Information]
  • Wyburn, K., Chadban, S., Kwan, T., Alexander, S., Wu, H. (2013). Interleukin-18 binding protein therapy is protective in adriamycin nephropathy. AJP: Renal Physiology (Online), 304(1), F68-F76. [More Information]
  • Chan, M., Chadban, S. (2013). Nutritional Management of Kidney Transplant Recipients. In Joel D. Kopple, Shaul G Massry, Kamyar Kalantar-Zadeh (Eds.), Nutritional Management of Renal Disease, (pp. 563-580). London, UK: Elsevier.
  • Lim, W., Clayton, P., Wong, G., Campbell, S., Cohney, S., Russ, G., Chadban, S., McDonald, S. (2013). Outcomes of Kidney Transplantation From Older Living Donors. Transplantation, 95(1), 106-113. [More Information]
  • Wyld, M., Clayton, P., Jesudason, S., Chadban, S., Alexander, S. (2013). Pregnancy Outcomes for Kidney Transplant Recipients. American Journal of Transplantation, 13(12), 3173-3182. [More Information]
  • Gill, J., Schaeffner, E., Chadban, S., Dong, J., Rose, C., Johnston, O., Gill, J. (2013). Quantification of the early risk of death in elderly kidney transplant recipients. American Journal of Transplantation, 13(2), 427-432. [More Information]
  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Howard, K. (2013). Rationing scarce organs for transplantation: Healthcare provider perspectives on wait-listing and organ allocation. Clinical Transplantation, 27(1), 60-71. [More Information]
  • Damasiewicz, M., Magliano, D., Daly, R., Gagnon, C., Lu, Z., Sikaris, K., Ebeling, P., Chadban, S., Atkins, R., Kerr, P., et al (2013). Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. American Journal of Kidney Diseases, 62(1), 58-66. [More Information]
  • Ko, H., Yin, J., Wyburn, K., Wu, H., Eris, J., Hambly, B., Chadban, S. (2013). Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction. Nephrology, Dialysis, Transplantation, 28(2), 327-336. [More Information]
  • Mudaliar, H., Pollock, C., Gangadharan Komala, M., Chadban, S., Wu, H., Panchapakesan, U. (2013). The role of toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. AJP: Renal Physiology (Online), 305(2), F143-F154. [More Information]
  • Storhaug, H., Norvik, J., Toft, I., Eriksen, B., Lochen, M., Zykova, S., Solbu, M., White, S., Chadban, S., Jenssen, T. (2013). Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: A gender specific analysis from The Tromso Study. BMC Cardiovascular Disorders, 13(11), 1-10. [More Information]

2012

  • Damasiewicz, M., Magliano, D., Daly, R., Gagnon, C., Lu, Z., Ebeling, P., Chadban, S., Atkins, R., Kerr, P., Shaw, J., et al (2012). 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrology, 13(1), 1-8. [More Information]
  • Polkinghorne, K., Chadban, S. (2012). A decade after the KDOQI CKD guidelines: a perspective from Australia. American Journal of Kidney Diseases, 60(5), 725-726. [More Information]
  • Wu, H., Noordmans, G., O'Brien, M., Ma, J., Zhao, C., Zhang, G., Kwan, T., Alexander, S., Chadban, S. (2012). Absence of MyD88 Signaling Induces Donor-Specific Kidney Allograft Tolerance. Journal of the American Society of Nephrology, 23(10), 1701-1716. [More Information]
  • Lim, W., Clayton, P., Wong, G., Dogra, G., Budgeon, C., Murray, K., Campbell, S., Cohney, S., Russ, G., Polkinghorne, K., Chadban, S., et al (2012). Association between initial and pretransplant dialysis modality and graft and patient outcomes in live- and deceased-donor renal transplant recipients. Transplant International, 25(10), 1032-1040. [More Information]
  • Johnson, D., Jones, G., Mathew, T., Ludlow, M., Chadban, S., Usherwood, T., Polkinghorne, K., Colagiuri, S., Jerums, G., Macisaac, R., et al (2012). Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Medical Journal of Australia, 197(4), 1-6. [More Information]
  • Irving, M., Tong, A., Jan, S., Cass, A., Chadban, S., Allen, R., Craig, J., Wong, G., Howard, K. (2012). Community attitudes to deceased organ donation: a focus group study. Transplantation, 93(10), 1064-1069. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Tong, A., Webster, A., Craig, J. (2012). Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One, 7(1), 1-9. [More Information]
  • Naresh, C., Hayen, A., Craig, J., Chadban, S. (2012). Day-to-Day Variability in Spot Urine Protein-Creatinine Ratio Measurements. American Journal of Kidney Diseases, 60(4), 561-566. [More Information]
  • Irving, M., Tong, A., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J., Wong, G., Howard, K. (2012). Factors that influence the decision to be an organ donor: a systematic review of the qualitative literature. Nephrology, Dialysis, Transplantation, 27(6), 2526-2533. [More Information]
  • Wong, G., Howard, K., Chapman, J., Pollock, C., Chadban, S., Salkeld, G., Tong, A., Williams, N., Webster, A., Craig, J. (2012). How do people with chronic kidney disease value cancer-related quality of life? Nephrology, 17(1), 32-41. [More Information]
  • Lim, W., Chadban, S., Clayton, P., Budgeon, C., Murray, K., Campbell, S., Cohney, S., Russ, G., McDonald, S. (2012). Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clinical Transplantation, 26(4), E428-E437. [More Information]
  • Chadban, S., Barraclough, K., Campbell, S., Clark, C., Coates, P., Cohney, S., Cross, N., Eris, J., Henderson, L., Howell, M., O'Connell, P., Webster, A., Wong, G., et al (2012). KHA-CARI guideline: KHA-CARI Adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology, 17(3), 204-214. [More Information]
  • Lim, W., Dogra, G., Chadban, S., Campbell, S., Clayton, P., Cohney, S., Russ, G., McDonald, S. (2012). Lack of impact of donor age on patient survival for renal transplant recipients (greater than or equal to) 60 years. Transplant International, 25(4), 401-408. [More Information]
  • Clayton, P., McDonald, S., Chapman, J., Chadban, S. (2012). Mycophenolate Versus Azathioprine for Kidney Transplantation: A 15-Year Follow-Up of a Randomized Trial. Transplantation, 94(2), 152-158. [More Information]
  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Marren, N., Howard, K. (2012). Patient preferences for the allocation of deceased donor kidneys for transplantation: a mixed methods study. BMC Nephrology, 13(1), 1-9. [More Information]
  • Tong, A., Jan, S., Wong, G., Craig, J., Irving, M., Chadban, S., Cass, A., Marren, N., Howard, K. (2012). Patient Preferences For The Allocation Of Deceased Donor Kidneys For Transplantation: A Mixed Methods Study. The Transplantation Society of Australia and New Zealand (TSANZ) 30th Annual Scientific Meeting (ASM), Manning Clark Centre, ANU Campus, Canberra ACT, Australia.
  • Roberts, D., Jiang, S., Chadban, S. (2012). The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients-A Systematic Review. Transplantation, 94(8), 775-783. [More Information]

2011

  • Lim, W., Chadban, S., Campbell, S., Cohney, S., Russ, G., McDonald, S. (2011). A review of utility-based allocation strategies to maximize graft years of deceased donor kidneys. Nephrology, 16(4), 368-376. [More Information]
  • Howard, K., Jan, S., Rose, J., Chadban, S., Allen, R., Irving, M., Tong, A., Wong, G., Craig, J., Cass, A. (2011). Community Preferences for the Allocation & Donation of Organs - The PAraDOx Study. BMC Public Health, 11(386), 386-1-386-7. [More Information]
  • Howard, K., Irving, M., Cass, A., Rose, J., Chadban, S., Allen, R., Tong, A., Wong, G., Craig, J., Jan, S. (2011). Community preferences for the allocation and donation of organs - The PArADOx Study: Preferences for organ donation. 11th Congress of the International Society for Organ Donation and Procurement, Amsterdam, Netherlands: Elsevier.
  • White, S., Yu, R., Craig, J., Polkinghorne, K., Atkins, R., Chadban, S. (2011). Diagnostic Accuracy of Urine Dipsticks for Detection of Albuminuria in the General Community. American Journal of Kidney Diseases, 58(1), 19-28. [More Information]
  • Chan, M., Patwardhan, A., Ryan, C., Trevillian, P., Chadban, S., Westgarth, F., Fry, K. (2011). Evidence-based guidelines for the nutritional management of adult kidney transplant recipients. Journal of Renal Nutrition, 21(1), 47-51. [More Information]
  • Maple-Brown, L., Cunningham, J., Hodge, A., Weeramanthri, T., Dunbar, T., Lawton, P., Zimmet, P., Chadban, S., Polkinghorne, K., Shaw, J., et al (2011). High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study. BMC Public Health, 11, 346-1-346-8. [More Information]
  • White, S., Dunstan, D., Polkinghorne, K., Atkins, R., Cass, A., Chadban, S. (2011). Physical inactivity and chronic kidney disease in Australian adults: The AusDiab study. Nutrition, Metabolism and Cardiovascular Diseases, 21(2), 104-112. [More Information]
  • White, S., Polkinghorne, K., Chadban, S. (2011). Population prevalance of proteinuria and diagnostic accuracy of urine dipsticks. American Journal of Kidney Diseases, 58. [More Information]
  • Clayton, P., McDonald, S., Chadban, S. (2011). Steroids and Recurrent IgA Nephropathy After Kidney Transplantation. American Journal Of Transplantation, 11(8), 1645-1649. [More Information]
  • Tong, A., Howard, K., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J. (2011). Systematic review and synthesis of quantitative and qualitative research: a worked example to assess community preferences. 19th Cochrane Colloquium, Hoboken, New Jersey: John Wiley & Sons.
  • Wong, G., Howard, K., Chapman, J., Tong, A., Bourke, M., Hayen, A., Macaskill, P., Hope, R., Williams, N., Kieu, A., Allen, R., Chadban, S., Pollock, C., Webster, A., Craig, J., et al (2011). Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health, 11(June), 516-(7pp). [More Information]
  • Chen, G., Wu, H., Ma, J., Chadban, S., Sharland, A. (2011). Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 26(12), 3873-3881. [More Information]

2010

  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Cass, A., Campbell, D., Tong, A., Tong, A., Colagiuri, R., Colagiuri, S., Craig, J., et al (2010). Assessment of kidney function in type 2 diabetes. Nephrology, 15(S1), S146-S161. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Campbell, D., Thomas, M., Jerums, G., Nicholls, K., Cass, A., Tong, A., Mangos, G., et al (2010). Assessment of kidney function in type 2 diabetes. Nephrology, 15 Sup1, S146-161. [More Information]
  • Matsushita, K., van der Velde, M., Astor, B., Woodward, M., Levey, A., de Jong, P., Coresh, J., Gansevoort, R., Tonelli, M., Atkins, R., et al (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet, 375(9731), 2073-2081. [More Information]
  • Tong, A., Howard, K., Jan, S., Cass, A., Rose, J., Chadban, S., Allen, R., Craig, J. (2010). Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation, 89(7), 796-805. [More Information]
  • White, S., Polkinghorne, K., Atkins, R., Chadban, S. (2010). Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. American Journal of Kidney Diseases, 55(4), 660-670. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Cass, A., Campbell, D., Nicholls, K., Tong, A., Mangos, G., et al (2010). Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes. Nephrology, 15(Sup 1), S195-S203. [More Information]
  • Howard, K., White, S., Salkeld, G., McDonald, S., Craig, J., Chadban, S., Cass, A. (2010). Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis. Value in Health, 13(2), 196-208. [More Information]
  • Lim, W., Chang, S., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Donor-recipient age matching improves years of graft function in deceased-donor kidney transplantation. Nephrology, Dialysis, Transplantation, 25(9), 3082-3089. [More Information]
  • Lim, W., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transplant International, 23(12), 1207-1215. [More Information]
  • Wu, H., Ma, J., Wang, P., Corpuz, T., Panchapakesan, U., Wyburn, K., Chadban, S. (2010). HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. Journal of the American Society of Nephrology, 21(11), 1878-1890. [More Information]
  • Lim, W., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2010). Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients. Nephrology, 15(3), 368-376. [More Information]
  • Tapp, R., O'Neil, A., Shaw, J., Zimmet, P., Oldenburg, B., Chadban, S., AusDiab Study, G. (2010). Is There a Link Between Components of Health-Related Functioning and Incident Impaired Glucose Metabolism and Type 2 Diabetes?: The Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care, 33(4), 757-762. [More Information]
  • Wong, G., Howard, K., Chapman, J., Cross, N., Chadban, S., Webster, A., Craig, J. (2010). Life years gain and cost-savings on the kidney transplant waiting list. Transplantation, 90(Suppl 972), 972.
  • Chadban, S., Wu, H., Hughes, J. (2010). Macrophages and Kidney Transplantation. Seminars in Nephrology, 30(3), 278-289. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Cass, A., Campbell, D., Nicholls, K., Tong, A., Mangos, G., et al (2010). Prevention and management of chronic kidney disease in type 2 diabetes. Nephrology, 15(S1), S162-S194. [More Information]
  • Smith, G., Trauer, T., Kerr, P., Chadban, S. (2010). Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. American Journal of Kidney Diseases, 55(4), 698-707. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Pollock, C., Phoon, R., Snelling, P., Tong, A., Salkeld, G., Webster, A., Craig, J. (2010). Quality of life of people with chronic kidney disease and cancer (QUICK) Study. Nephrology, 15(S4), 33-33. [More Information]
  • Pilmore, H., Dent, H., Chang, S., McDonald, S., Chadban, S. (2010). Reduction in Cardiovascular Death After Kidney Transplantation. Transplantation, 89(7), 851-857. [More Information]
  • Mathew, T., Corso, O., Ludlow, M., Boyle, A., Cass, A., Chadban, S., Joyner, B., Shephard, M., Usherwood, T. (2010). Screening for chronic kidney disease in Australia: a pilot study in the community and workplace. Kidney International, 77(Supplement 116), S9-S16. [More Information]
  • Wong, G., Howard, K., Chapman, J., Chadban, S., Cross, N., Webster, A., Craig, J. (2010). Survival Benefits of Kidney Transplantation: Absolute Against Incremental Gains In Life Years. Transplantation, 90(Suppl:971), 971.
  • Lynch, B., White, S., Owen, N., Healy, G., Chadban, S., Atkins, R., Dunstan, D. (2010). Television Viewing Time and Risk of Chronic Kidney Disease in Adults: The AusDiab Study. Annals of Behavioral Medicine, 40(3), 265-274. [More Information]
  • Chadban, S., Clayton, P., Excell, L., Campbell, S., McDonald, S. (2010). Transplantation. In S. McDonald, L. Excell, B. Livingstone (Eds.), ANZDATA Registry Report 2010, (pp. 1-31). Australia: ANZDATA Registry Australia.

2009

  • White, S., Polkinghorne, K., Cass, A., Shaw, J., Atkins, R., Chadban, S. (2009). Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrology, Dialysis, Transplantation, 24(8), 2464-2472. [More Information]
  • Fry, K., Patwardhan, A., Ryan, C., Trevillian, P., Chadban, S., Westgarth, F., Chan, M. (2009). Development of evidence-based guidelines for the nutritional management of adult kidney transplant recipients. Journal of Renal Nutrition, 19(1), 101-104. [More Information]
  • Villar, E., Polkinghorne, K., Chang, S., Chadban, S., McDonald, S. (2009). Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease. Diabetologia: clinical and experimental diabetes and metabolism, 52(12), 2536-2541. [More Information]
  • Chadban, S., Howell, M., Twigg, S., Thomas, M., Jerums, G., Nicholls, K., Mangos, G., Tong, A., Stack, A., McIsaac, R., Girgis, S., Colagiuri, S., Colagiuri, R., Craig, J. (2009).
  • Lim, W., Chang, S., Chadban, S., Campbell, S., Dent, H., Russ, G., McDonald, S. (2009). Interleukin-2 Receptor Antibody Reduces Rejection Rates and Graft Loss in Live-Donor Kidney Transplant Recipients. Transplantation, 88(10), 1208-1213. [More Information]
  • White, S., Perkovic, V., Cass, A., Chang, C., Poulter, N., Spector, T., Haysom, L., Craig, J., Al Salmi, I., Chadban, S., Huxley, R. (2009). Is Low Birth Weight an Antecedent of CKD in Later Life? A Systematic Review of Observational Studies. American Journal of Kidney Diseases, 54(2), 248-261. [More Information]
  • Tong, A., Sainsbury, P., Chadban, S., Walker, R., Harris, D., Carter, S., Hall, B., Hawley, C., Craig, J. (2009). Patients' Experiences and Perspectives of Living With CKD. American Journal of Kidney Diseases, 53(4), 689-700. [More Information]
  • Howard, K., Salkeld, G., White, S., McDonald, S., Chadban, S., Craig, J., Cass, A. (2009). The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology, 14(1), 123-132. [More Information]

2008

  • Kondalsamy-Chennakesavan, S., Hoy, W., Wang, Z., Briganti, E., Polkinghorne, K., Chadban, S., Shaw, J. (2008). Anthropometric measurements of Australian Aboriginal adults living in remote areas: Comparison with nationally representative findings. American Journal of Human Biology, 20, 317-324. [More Information]
  • Walker, R., Thomas, M., Goodman, D., Campbell, S., Chadban, S., AUS-13 Study, G. (2008). Combination therapy with tacrolimus and mycophenolate mofetil: effects of early and late minimization of mycophenolate mofetil after renal transplant. Clinical Transplantation, 22(5), 594-602. [More Information]
  • Craig, J., Perkovic, V., Chadban, S., Cass, A., McDonald, S., Salkeld, G., Howard, K., White, S. (2008). Cost effectiveness of screening for the early diagnosis and treatment of risk factors for chronic kidney disease: a Markov Monte Carlo microsimulation using marck-E (model for the assessment of risk factors for chronic kidney disease - economics). 42nd Australia and New Zealand Society of Nephrology Annual Scientific Conference (2006), United States of America: Wiley-Blackwell Publishing.
  • Ko, H., Hambly, B., Eris, J., Levidiotis, V., Wyburn, K., Wu, H., Chadban, S., Yin, J. (2008). Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A. Transplant Immunology, 20(1-2), 99-105. [More Information]
  • Perkovic, V., Cass, A., Patel, A., Suriyawongpaisal, P., Barzi, F., Chadban, S., MacMahon, S., Neal, B. (2008). High prevalence of chronic kidney disease in Thailand. Kidney International, 73(4), 473-479. [More Information]
  • White, S., Chadban, S., Jan, S., Chapman, J., Cass, A. (2008). How can we achieve global equity in provision of renal replacement therapy. Bulletin of the World Health Organization, 86(3), 229-237. [More Information]
  • Wu, H., Craft, M., Wang, P., Wyburn, K., Chen, G., Ma, J., Hambly, B., Chadban, S. (2008). IL-18 Contributes to Renal Damage after Ischemia-Reperfusion. Journal of the American Society of Nephrology, 19(12), 2331-2341. [More Information]
  • Chadban, S., Morris, R., Hirschc, H., Bunnapradist, S., Arns, W., Budde, K. (2008). Immunosuppression in renal transplantation: some aspects for the modern era. Transplantation Reviews, 22, 241-251. [More Information]
  • White, S., Polkinghorne, K., Cass, A., Shaw, J., Atkins, R., Chadban, S. (2008). Limited knowledge of kidney disease in a survey of AusDiab study participants. Medical Journal of Australia, 188(4), 204-208. [More Information]
  • Chadban, S. (2008). New-onset diabetes after transplantation - should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients? Nephrology, Dialysis, Transplantation, 23(6), 1816-1818. [More Information]
  • Garry, L., Mawson, J., George, C., Chadban, S., Allen, R., Eris, J., Verran, D. (2008). Outcomes of Patients Seeking Commercial Renal Allograft Transplantation Outside of Australia. Transplantation, 86(2S (supplement)), 266-266.
  • Tong, A., Sainsbury, P., Carter, S., Hall, B., Harris, D., Walker, R., Hawley, C., Chadban, S., Craig, J. (2008). Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(10), 3206-3214. [More Information]
  • White, S., McGeechan, K., Jones, M., Cass, A., Chadban, S., Polkinghorne, K., Perkovic, V., Roderick, P. (2008). Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand. American Journal of Public Health, 98(7), 1306-1313. [More Information]
  • Chang, S., Russ, G., Chadban, S., Campbell, S., McDonald, S. (2008). Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991–2005. Nephrology, 13(2), 171-176. [More Information]

2007

  • Chadban, S., Baines, L., Polkinghorne, K., Jeffreys, A., Dogra, S., Kanganas, C., Irish, A., Eris, J., Walker, R. (2007). Anemia After Kidney Transplantation Is Not Completely Explained by Reduced Kidney Function. American Journal of Kidney Diseases, 49(2), 301-309. [More Information]
  • Killen, J., Chadban, S. (2007). Antithymocyte globulin versus basiliximab in renal transplantation. New England Journal of Medicine, 356(6), 634-635. [More Information]
  • Chadban, S. (2007). Chronic Allograft Dysfunction. In David Harris (Eds.), Clinical Cases in Kidney Disease. Australia: McGraw Hill.
  • McClintock, C., Cass, A., Chadban, S. (2007). How to treat: Chronic Kidney Disease. Australian Doctor, (February 2), 19-23.
  • Magliano, D., Polkinghorne, K., Barr, E., Su, Q., Chadban, S., Zimmet, P., Shaw, J., Atkins, R. (2007). HPLC-Detected Albuminuria Predicts Mortality. Journal of the American Society of Nephrology, 18(12), 3171-3176. [More Information]
  • McDonald, S., Russ, G., Campbell, S., Chadban, S. (2007). Kidney Transplant Rejection in Australia and New Zealand: Relationships between rejection and graft outcome. American Journal Of Transplantation, 7(5), 1201-1208. [More Information]
  • Hoy, W., Kondalsamy-Chennakesavan, S., Wang, Z., Briganti, E., Shaw, J., Polkinghorne, K., Chadban, S. (2007). Quantifying the excess risk for proteinuria, hypertension and diabetes in Australian Aborigines: comparison of profiles in three remote communities in the Northern Territory with those in the AusDiab study. Australian and New Zealand Journal of Public Health, 31(2), 177-183. [More Information]
  • Cass, A., Chadban, S., Gallagher, M., Howard, K., Kneipp, E., McDonald, S., Snelling, P. (2007). Queensland Statewide Renal Health Services Plan 2007-2017 - Part Two: Current Service Analysis and Future Demand Predictions.
  • Yi, S., Wang, Y., Chandra, A., O'Hara, J., Wu, J., Ouyang, L., Burgess, J., Hawthorne, W., Wu, H., Chadban, S., O'Connell, P. (2007). Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer. Transplantation, 83(5), 615-623. [More Information]
  • Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J., Uchida, K., Pescovitz, M., Marchetti, P., Tuncer, M., Chadban, S., et al (2007). Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus. American Journal Of Transplantation, 7(6), 1506-1514. [More Information]
  • Wu, H., Chen, G., Wyburn, K., Bertolino, P., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. Journal of Clinical Investigation, 117(10), 2847-2859. [More Information]
  • Chang, S., Russ, G., Chadban, S., Campbell, S., McDonald, S. (2007). Trends in Kidney Transplantation in Australia and New Zealand, 1993-2004. Transplantation, 84(5), 611-618. [More Information]

2006

  • Chadban, S., Campbell, S., Russ, G., Walker, R., Chapman, J., Pussell, B., Trevillian, P., Ierino, F., Thompson, N., Hutchison, B., et al (2006). A one-year, randomised, open label, parallel group study to investigate the safety and efficacy of enteric-coated Mycophenolate sodium (EC-MPS) in combination with full dose or reduced dose cyclosporine microemulsion (CSA-ME), basiliximab and steroids in de novo kidney transplantation. Immunology and Cell Biology, 84(3), A6-A6.
  • Salkeld, G., Howard, K., McDonald, S., Cass, A., Chadban, S., White, S., Craig, J. (2006). Cost effectiveness of renal replacement therapy for patients with end stage kidney disease: a Markov microsimulation model. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., Cass, A., McDonald, S., Perkovic, V. (2006). Cost effectiveness of screening for the early diagnosis and treatment of risk factors for chronic kidney disease: A Markov Monte Carlo microsimulation using Marck-E. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Yu, R., Craig, J., Polkinghorne, K., Shaw, J., Atkins, R., Chadban, S. (2006). Dipstick urinalysis for the detection of proteinuria in the general community. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Buchler, M., Chadban, S., Cole, E., Midtvedt, K., Thervet, E., Prestele, H., Keown, P. (2006). Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Nephrology, Dialysis, Transplantation, 21(1), 197. [More Information]
  • Wyburn, K., Wu, H., Chen, G., Yin, J., Eris, J., Chadban, S. (2006). Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. American Journal Of Transplantation, 6(11), 2612-2621. [More Information]
  • Nguyen, D., Ping, F., Mu, W., Hill, P., Atkins, R., Chadban, S. (2006). Macrophage accumulation in human progressive diabetic nephropathy. Nephrology, 11(3), 226-231. [More Information]
  • Polkinghorne, K., Su, Q., Chadban, S., Shaw, J., Zimmet, P., Atkins, R. (2006). Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography. American Journal of Kidney Diseases, 47(4), 604-613. [More Information]
  • McDonald, S., Howard, K., White, S., Craig, J., Chadban, S., Salkeld, G., Cass, A. (2006). Predicting future requirements for renal replacement therapy (RRT) in Australia. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology.
  • Ko, H., Yin, J., Hambly, B., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2006). Rapamycin and Sanglifehrin A can inhibit interleukin-18 production from dendritic cells in vitro and in vivo. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., McDonald, S., Perkovic, V., Cass, A. (2006). The cost-effectiveness of early detection and intervention to prevent the progression of Chronic Kidney Disease in Australia.
  • Howard, K., Salkeld, G., White, S., Chadban, S., Craig, J., McDonald, S., Perkovic, V., Cass, A. (2006). The Cost-Effectiveness of Early Detection and Intervention to Prevent the Progression of Chronic Kidney Disease in Australia.
  • Cass, A., Chadban, S., Craig, J., Howard, K., McDonald, S., Salkeld, G., White, S. (2006). The economic impact of end-stage kidney disease in Australia.
  • Cass, A., Chadban, S., Craig, J., Howard, H., McDonald, S., Salkeld, G., White, S. (2006). The Economic Impact of End-Stage Kidney Disease in Australia.
  • Eykman, L., Mawson, J., Robertson, P., Chadban, S., Allen, R. (2006). The monetary cost of living kidney donation. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Yin, J., Ko, H., Wyburn, K., Wu, H., Hambly, B., Chadban, S., Eris, J. (2006). The role of IL-12 family cytokines in chronic allograft nephropathy. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.
  • Wu, H., Chen, G., Wyburn, K., Afifi, M., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2006). TLR4 activation mediates kidney ischemia reperfusion injury. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.

2005

  • Cass, A., Chadban, S., Atkins, R., White, S. (2005). Chronic kidney disease in the general population. Advances in Chronic Kidney Disease, 12(1), 5-13. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased Kidney Donor Suitability Guidelines. Nephrology, 10(Supplement 4), S116-S132. [More Information]
  • Verran, D., Robertson, A., Chapman, J., Chadban, S. (2005). Deceased kidney donor suitability guidelines: Non-heart-beating donors. Nephrology, 10(S4), S116-S119. [More Information]
  • Benseler, V., Bishop, A., Chng, K., Watson, J., Wang, C., Dahlke, M., Koutalistras, N., Watts, A., Hawthorne, W., McKenzie, P., Hennessy, A., Pleass, H., Chadban, S., Schlitt, H., McCaughan, G., et al (2005). Development of a primate model to evaluate strategies to achieve long term renal allograft acceptance. Immunology and Cell Biology, 83(4 Suppl.), A26-A26.
  • Stefoni, S., Midtved, K., Cole, E., Thervet, E., Cockfield, S., Buchler, M., Toselli, L., Pallardo, L., Schena, F., Pilmore, H., Chadban, S., et al (2005). Efficacy and safety outcomes among de novo renal transplant recipients managed by C-2 monitoring of cyclosporine A microemulsion: Results of a 12-month, randomized, multicenter study. Transplantation, 79(5), 577-583. [More Information]
  • Chadban, S., Atkins, R. (2005). Glomerulonephritis. The Lancet, 365(9473), 1797-1806. [More Information]
  • Ko, H., Yin, J., Hambly, B., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2005). Immunosuppressants rapamycin and sanglifehrin A inhibit bioactive IL-18 production by dendritic. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Kusyk, T., Verran, D., Stewart, G., Ryan, B., Fisher, J., Tsacalos, K., Chadban, S., Eris, J. (2005). Increased risk of hemorrhagic complications in renal allograft recipients receiving systemic heparin early posttransplantation. Transplantation Proceedings, 37(2), 1026-1028. [More Information]
  • Wyburn, K., Wu, H., Yin, J., Jose, M., Eris, J., Chadban, S. (2005). Interleukin-18 is elevated in experimental renal allograft rejection. 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Blazik, M., Hutchinson, P., Jose, M., Polkinghorne, K., Holdsworth, S., Atkins, R., Chadban, S. (2005). Leukocyte phenotype and function predicts infection risk in renal transplant recipients. Nephrology, Dialysis, Transplantation, 20(10), 2226-2230. [More Information]
  • Wyburn, K., Wu, H., Yin, J., Jose, M., Eris, J., Chadban, S. (2005). Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrology, Dialysis, Transplantation, 20(4), 699-706. [More Information]
  • Buchler, M., Chadban, S., Cole, E., Midtvedt, K., Thervet, E., Prestele, H., Keown, O. (2005). Pharmacokinetics of cyclosporine-microemulsion after renal transplantation: How long does C2-monitoring add value? 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Yin, J., Wyburn, K., Wu, H., Chadban, S., Eris, J. (2005). The role of IL-18 and IL-12 family in chronic allograft nephropathy. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Wyburn, K., Jose, M., Wu, H., Atkins, R., Chadban, S. (2005). The Role of Macrophages in Allograft Rejection. Transplantation, 80(12), 1641-1647. [More Information]
  • Yu, R., Chadban, S., Svara, F., Sen, S., Eris, J. (2005). Two cases of delayed cyclosporin absorption leading to CsA exposure higher than that predicted by C2 monitoring alone. Nephrology, Dialysis, Transplantation, 20(8), 1745-1747. [More Information]
  • Wu, H., Wyburn, K., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2005). Upregulation of NKG2D and it''s ligand RAE-1 in renal allografts may provide a link between innate and adaptive immunity in acute rejection. 6th American Transplant Congress, Oxford, UK: Blackwell Publishing Professionals.
  • Wu, H., Wyburn, K., Yin, J., Eris, J., Alexander, S., Sharland, A., Chadban, S. (2005). Upregulation of NKG2D and its ligand RAE-1 in renal allografts may provide a link between innate and adaptive immunity in acute rejection. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Australia: Wiley-Blackwell Publishing Asia Pty Ltd.
  • Chadban, S., Ierino, F. (2005). Welcome to the era of CKD and the eGFR: Estimating glomerular filtration rate using a simplified formula will lead to a vast increase in detection of chronic kidney disease in Australia [Editorial]. Medical Journal of Australia, 183(3), 117-118. [More Information]

2004

  • Atkins, R., Polkinghorne, K., Briganti, E., Shaw, J., Zimmet, P., Chadban, S. (2004). Prevalence of albuminuria in Australia: The AusDiab Kidney Study. Kidney International, 66(Supplement 92), S22-S24.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment For Lupus Nephritis. Cochrane Database of Systematic Reviews, 1(CD002922), 1-79.
  • Flanc, R., Roberts, M., Strippoli, G., Chadban, S., Kerr, P., Atkins, R. (2004). Treatment Of Diffuse Proliferative Lupus Nephritis: A Meta-Analysis Of Randomized Controlled Trials. American Journal of Kidney Diseases, 43(2), 197-208.

2003

  • Atkins, R., Briganti, E., Zimmet, P., Chadban, S. (2003). Association between albuminuria and proteinuria in the general population: the AusDiab study. Nephrology, Dialysis, Transplantation, 18(10), 2170-2174.
  • Jose, M., Le Meur, Y., Atkins, R., Chadban, S. (2003). Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. American Journal Of Transplantation, 3(3), 294-300.
  • Thervet, E., Pfeffer, P., Scolari, M., Toselli, L., Pallardo, L., Chadban, S., Pilmore, H., Connolly, J., Buchler, M., Schena, F., et al (2003). Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation, 76(6), 903-908.
  • Jose, M., Ikezumi, Y., Van Rooijen, N., Atkins, R., Chadban, S. (2003). Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation, 76(7), 1015-1022.
  • Chadban, S., Briganti, E., Kerr, P., Dunstan, D., Welborn, T., Zimmet, P., Atkins, R. (2003). Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. Journal of the American Society of Nephrology, 14, S131-S138.
  • Smith, G., Trauer, T., Kerr, P., Chadban, S. (2003). Prospective psychosocial monitoring of living kiney donors using the SF-36 health survey. Transplantation, 76(5), 807-809.
  • Briganti, E., Shaw, J., Chadban, S., Zimmet, P., Welbron, T., McNeil, J., Atkins, R. (2003). Untreated hypertension among Australian adults: the 1999-2000 Australian diabetes, obesity and lifestyle study (AusDiab). Medical Journal of Australia, 179(3), 135-139.

To update your profile click here. For support on your academic profile contact .